Enrichment and detection of molecules secreted by tumor cells using magnetic reversed-phase particles and LC-MALDI-TOF-MS

Journal of Biomolecular Techniques

Volumn 18, Issue 5, 2007, Pages 287-297

  Peter, Jochen F ^a,b   Otto, Angela M ^b,c   Wolf, Bernhard ^a,b,c  

^a Steinbeis Center for Cell Chip Technologies   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c Central Institute for Medical Engineering   (Germany)

Author keywords

Cancer cells; LC MALDI; Magnetic RP particles; Serum surrogate

Indexed keywords

MICROSPHERE; PEPTIDE;

ANIMAL; ARTICLE; BREAST TUMOR; CATTLE; CELL PROLIFERATION; CHEMISTRY; CULTURE MEDIUM; FEMALE; FETUS BLOOD; HUMAN; ISOLATION AND PURIFICATION; LIQUID CHROMATOGRAPHY; MAGNETISM; MASS SPECTROMETRY; PARTICLE SIZE; PHYSIOLOGY; SECRETION; TUMOR CELL LINE; VALIDATION STUDY;

ANIMALS; BREAST NEOPLASMS; CATTLE; CELL LINE, TUMOR; CELL PROLIFERATION; CHROMATOGRAPHY, LIQUID; CULTURE MEDIA; FEMALE; FETAL BLOOD; HUMANS; MAGNETICS; MICROSPHERES; PARTICLE SIZE; PEPTIDES; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 38949168977     PISSN: 15240215     EISSN: 19434731     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Evtimova V, Zeillinger R, Weidle UH. Identification of genes associated with the invasive status of human mammary carcinoma cell lines by transcriptional profiling. Tumour Biol 2003;24(4):189-198.
2. Gygi SP, Rochon Y, Franza BR, Aebersold R. Correlation between protein and mRNA abundance in yeast. Mol Cell Biol 1999;19(3):1720-1730.
3. Gewartowski K, Tomecki R, Muchowski L, Dmochow-Ska A, Dzwonek A, Malecki M, et al. Up-regulation of human PNPase mRNA by beta-interferon has no effect on protein level in melanoma cell lines. Acta Biochim Pol 2006;53(1):179-188.
4. Chen G, Gharib TG, Huang CC, Taylor JM, Misek DE, Kardia SL, et al. Discordant protein and mRNA expression in lung adenocarcinomas. Mol Cell Proteomics 2002;1(4):304-313.
5. Tong D, Schneeberger C, Czerwenka K, Schmutzler RK, Speiser P, Kucera E, et al. Messenger RNA determination of estrogen receptor, progesterone receptor, pS2, and plasminogen activator inhibitor-1 by competitive reverse transcription-polymerase chain reaction in human breast cancer. Clin Cancer Res 1999;5(6):1497-1502.
6. Jungblut PR, Zimny-Arndt U, Zeindl-Eberhard E, Stulik J, Koupilova K, Pleissner KP, et al. Proteomics in human disease: Cancer, heart and infectious diseases. Electrophoresis 1999;20(10):2100-2110.
7. Alexander H, Stegner AL, Wagner-Mann C, Du Bois GC, Alexnder S, Sauter ER. Proteomic analysis to identify breast cancer biomarkers in nipple aspirate fluid. Clin Cancer Res 2004;10(22):7500-7510.
8. Peter JF, Unverzagt C, Krogh TN, Vorm O, Hoesel W. Identification of precursor forms of free prostate-specific antigen in serum of prostate cancer patients by immunosorption and mass 21 spectrometry. Cancer Res 2001;61(3):957-962.
9. Peter JF, Unverzagt C, Hoesel W. Analysis of free prostate-specific antigen (PSA) after chemical release from the complex with alpha(1)-antichymotrypsin (PSA-ACT). Clin Chem 2000;46(4):474-482.
10. Anderson NL, Anderson NG. The human plasma proteome: History, character, and diagnostic prospects. Mol Cell Proteomics 2002;1(11):845-867.
11. Brand J, Haslberger T, Zolg W, Pestlin G, Palme S. Depletion 24 efficiency and recovery of trace markers from a multiparameter immunodepletion column. Proteomics 2006;6(11):3236-3242.
12. Camerini S, Polci ML, Liotta LA, Petricoin EF, Zhou W. A method for the selective isolation and enrichment of carrier protein-bound low-molecular weight proteins and peptides in blood. Proteomics Clin Appl 2007;1(2):176-184.
13. Lowenthal MS, Mehta AI, Frogale K, Bandle RW, Araujo RP, Hood BL, et al. Analysis of albumin-associated peptides and proteins from ovarian cancer patients. Clin Chem 2005;51(10):1-13.
14. Castellón E., Venegas K., Sáenz L., Contreras H, Huidobro C. Secretion of prostatic specific antigen, proliferative activity and 27 androgen response in epithelialstromal co-cultures from human prostate carcinoma. Int J Androl 2005;28(1):39-46.
15. Kratchmarova I, Kalume DE, Blagoev B, Scherer PE, Podtelejnikov AV, Molina H, et al. A proteomic approach for identification 28 of secreted proteins during the differentiation of 3T3-L1 preadipocytes to adipocytes. Mol Cell Proteomics 2002;1(3):213-222.
16. Zwickl H, Traxler E, Staettner S, Parzefall W, Grasl-Kraupp B, Karner J, et al. A novel technique to specifically analyze the secretome of cells and tissues. Electrophoresis 2005;26(14):2779-2785.
17. Sato K, Sasaki K, Akiyama Y, Yamaguchi K. Mass spectrometric high-throughput analysis of serum-free conditioned medium from cancer cell lines. Cancer Lett 2001;170(2):153-159.
18. Sato K, Sasaki K, Tsao MS, Yamaguchi K. Peptide differential display of serum-free conditioned medium from cancer cell lines. Cancer Lett 2002;176(2):199-203.
19. Warburton MJ, Poole B. Effect of medium composition on protein degradation and DNA synthesis in rat embryo fibroblasts. Proc Natl Acad Sci USA 1977;74(6):2427-2431.
20. Mostafapour MK, Green H. Effects of withdrawal of a serum stimulus on the protein-synthesizing machinery of cultured fibroblasts. J Cell Physiol 1975;86(2 Pt 2 Suppl 1):313-319.
21. Plas DR, Thompson CB. Cell metabolism in the regulation of programmed cell death. Trends Endocrinol Metabol 2002;13(2): 75-78.
22. Hutchens TW, Yip TT. New desorption strategies for the mass spectrometric analysis of macromolecules. Rapid Commun Mass Spectrom 1993;7:576-580.
23. Davies H, Lomas L, Austen B. Profiling of amyloid beta peptide variants using SELDI ProteinChip arrays. Biotechniques 1999;27(6):1258-1262.
24. Marshall FF. Serum protein profiling by SELDI mass spectrometry: Detection of multiple variants of serum amyloid alpha in renal cancer patients. J Urol 2005;173(6):1919-1920.
25. Tolson J, Bogumil R, Brunst E, Beck H, Elsner R, Humeny A, et al. Serum protein profiling by SELDI mass spectrometry: Detection of multiple variants of serum amyloid alpha in renal cancer patients. Lab Invest 2004;84(7):845-856.
26. Doucette A, Craft D, Li L. Mass spectrometric study of the effects of hydrophobic surface chemistry and morphology on the digestion of surface-bound proteins. J Am Soc Mass Spectrom 2003;14(3):203-214.
27. Villanueva J, Shaffer DR, Philip J, Chaparro CA, Erdjument-Bromage H, Olshen AB, et al. Differential exoprotease activities confer tumor-specific serum peptidome patterns. J Clin Invest 2006;116(1):271-284.
28. de Noo ME, Tollenaar RA, Ozalp A, Kuppen PJ, Bladergroen MR, Eilers PH, et al. Reliability of human serum protein profiles generated with C8 magnetic beads assisted MALDI-TOF mass spectrometry. Anal Chem 2005;77(22):7232-7241.
29. Otto AM, Faderl M, Schonenberger H. Dissociation of estrogenic and cytotoxic properties of an estrogen receptor-binding platinum complex in human breast cancer cell lines. Cancer Res 1991;51(12):3217-3223.
30. Otto AM, Müller CS, Huff T, Hannappel E. Chemotherapeutic drugs change actin skeleton organization and the expression of β-thymosins in human breast cancer cells. J Cancer Res Clin Oncol 2002;128(5):247-256.